|
CEP78 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.922100E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.93439999573997E-08 |
| Stage1-vs-Stage2 |
3.113000E-01 |
| Stage1-vs-Stage3 |
5.962700E-03 |
| Stage1-vs-Stage4 |
8.883800E-01 |
| Stage2-vs-Stage3 |
4.696300E-02 |
| Stage2-vs-Stage4 |
3.389600E-01 |
| Stage3-vs-Stage4 |
1.713780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-15 |
| Normal-vs-AfricanAmerican |
1.64523950019202E-12 |
| Normal-vs-Asian |
4.226100E-02 |
| Caucasian-vs-AfricanAmerican |
9.445900E-02 |
| Caucasian-vs-Asian |
3.112600E-01 |
| AfricanAmerican-vs-Asian |
4.239500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62547753035369E-12 |
| Normal-vs-Female |
1.62547753035369E-12 |
| Male-vs-Female |
7.621600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18630000001119E-06 |
| Normal-vs-Age(41-60Yrs) |
4.81492623549684E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.73960845728516E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.542800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.563600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.386400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.707600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.483600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.163600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.208010E-04 |
| Normal-vs-Grade 2 |
1.77102776888205E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.7486999959182E-08 |
| Grade 1-vs-Grade 2 |
8.515800E-01 |
| Grade 1-vs-Grade 3 |
2.995000E-01 |
| Grade 1-vs-Grade 4 |
4.577200E-01 |
| Grade 2-vs-Grade 3 |
2.207500E-02 |
| Grade 2-vs-Grade 4 |
4.531400E-01 |
| Grade 3-vs-Grade 4 |
6.536000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
4.54380000292076E-09 |
| ccA subtype-vs-ccB subtype |
1.221560E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54209978120434E-13 |
| Normal-vs-N1 |
1.74197999999182E-05 |
| N0-vs-N1 |
7.331800E-01 |
|
|
